T Stacey1, Pwg Tennant2,3,4, Lme McCowan5, E A Mitchell6, J Budd7,8, M Li5, Jmd Thompson5,6, B Martin9, D Roberts10, Aep Heazell7,8. 1. School of Healthcare, University of Leeds, Leeds, UK. 2. Leeds Institute for Data Analytics, University of Leeds, Leeds, UK. 3. School of Medicine, University of Leeds, Leeds, UK. 4. The Alan Turing Institute, London, UK. 5. Department of Obstetrics and Gynaecology, The University of Auckland, Auckland, New Zealand. 6. Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand. 7. Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biological, Medical and Human Sciences, University of Manchester, Manchester, UK. 8. Manchester Academic Health Science Centre, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK. 9. Birmingham Women's Hospital NHS Foundation Trust, Birmingham, UK. 10. Liverpool Women's Hospital NHS Foundation Trust, Liverpool, UK.
Abstract
OBJECTIVE: To explore the separate effects of being 'at risk' of gestational diabetes mellitus (GDM) and screening for GDM, and of raised fasting plasma glucose (FPG) and clinical diagnosis of GDM, on the risk of late stillbirth. DESIGN: Prospective case-control study. SETTING: Forty-one maternity units in the UK. POPULATION: Women who had a stillbirth ≥28 weeks of gestation (n = 291) and women with an ongoing pregnancy at the time of interview (n = 733). METHODS: Causal mediation analysis explored the joint effects of (i) 'at risk' of GDM and screening for GDM and (ii) raised FPG (≥5.6 mmol/l) and clinical diagnosis of GDM on the risks of late stillbirth. Adjusted odds ratios (aOR) were estimated by logistic regression adjusted for confounders identified by directed acyclic graphs. MAIN OUTCOME MEASURES: Screening for GDM and FPG levels RESULTS: Women 'at risk' of GDM, but not screened, experienced 44% greater risk of late stillbirth than those not 'at risk' (aOR 1.44, 95% CI 1.01-2.06). Women 'at risk' of GDM who were screened experienced no such increase (aOR 0.98, 95% CI 0.70-1.36). Women with raised FPG not diagnosed with GDM experienced four-fold greater risk of late stillbirth than women with normal FPG (aOR 4.22, 95% CI 1.04-17.02). Women with raised FPG who were diagnosed with GDM experienced no such increase (aOR 1.10, 95% CI 0.31-3.91). CONCLUSIONS: Optimal screening and diagnosis of GDM mitigate the higher risks of late stillbirth in women 'at risk' of GDM and/or with raised FPG. Failure to diagnose GDM leaves women with raised FPG exposed to avoidable risk of late stillbirth. TWEETABLE ABSTRACT: Risk of #stillbirth in gestational diabetes is mitigated by effective screening and diagnosis.
OBJECTIVE: To explore the separate effects of being 'at risk' of gestational diabetes mellitus (GDM) and screening for GDM, and of raised fasting plasma glucose (FPG) and clinical diagnosis of GDM, on the risk of late stillbirth. DESIGN: Prospective case-control study. SETTING: Forty-one maternity units in the UK. POPULATION: Women who had a stillbirth ≥28 weeks of gestation (n = 291) and women with an ongoing pregnancy at the time of interview (n = 733). METHODS: Causal mediation analysis explored the joint effects of (i) 'at risk' of GDM and screening for GDM and (ii) raised FPG (≥5.6 mmol/l) and clinical diagnosis of GDM on the risks of late stillbirth. Adjusted odds ratios (aOR) were estimated by logistic regression adjusted for confounders identified by directed acyclic graphs. MAIN OUTCOME MEASURES: Screening for GDM and FPG levels RESULTS: Women 'at risk' of GDM, but not screened, experienced 44% greater risk of late stillbirth than those not 'at risk' (aOR 1.44, 95% CI 1.01-2.06). Women 'at risk' of GDM who were screened experienced no such increase (aOR 0.98, 95% CI 0.70-1.36). Women with raised FPG not diagnosed with GDM experienced four-fold greater risk of late stillbirth than women with normal FPG (aOR 4.22, 95% CI 1.04-17.02). Women with raised FPG who were diagnosed with GDM experienced no such increase (aOR 1.10, 95% CI 0.31-3.91). CONCLUSIONS: Optimal screening and diagnosis of GDM mitigate the higher risks of late stillbirth in women 'at risk' of GDM and/or with raised FPG. Failure to diagnose GDM leaves women with raised FPG exposed to avoidable risk of late stillbirth. TWEETABLE ABSTRACT: Risk of #stillbirth in gestational diabetes is mitigated by effective screening and diagnosis.
Authors: Tracy M Tomlinson; Alexandra M Johnson; Alexandra M Edwards; Gilad A Gross; Dorothea J Mostello Journal: Arch Gynecol Obstet Date: 2020-09-08 Impact factor: 2.344
Authors: Natalia Pervjakova; Gunn-Helen Moen; Maria-Carolina Borges; Teresa Ferreira; James P Cook; Catherine Allard; Robin N Beaumont; Mickaël Canouil; Gad Hatem; Anni Heiskala; Anni Joensuu; Ville Karhunen; Soo Heon Kwak; Frederick T J Lin; Jun Liu; Sheryl Rifas-Shiman; Claudia H Tam; Wing Hung Tam; Gudmar Thorleifsson; Toby Andrew; Juha Auvinen; Bishwajit Bhowmik; Amélie Bonnefond; Fabien Delahaye; Ayse Demirkan; Philippe Froguel; Kadri Haller-Kikkatalo; Hildur Hardardottir; Sandra Hummel; Akhtar Hussain; Eero Kajantie; Elina Keikkala; Amna Khamis; Jari Lahti; Tove Lekva; Sanna Mustaniemi; Christine Sommer; Aili Tagoma; Evangelia Tzala; Raivo Uibo; Marja Vääräsmäki; Pia M Villa; Kåre I Birkeland; Luigi Bouchard; Cornelia M Duijn; Sarah Finer; Leif Groop; Esa Hämäläinen; Geoffrey M Hayes; Graham A Hitman; Hak C Jang; Marjo-Riitta Järvelin; Anne Karen Jenum; Hannele Laivuori; Ronald C Ma; Olle Melander; Emily Oken; Kyong Soo Park; Patrice Perron; Rashmi B Prasad; Elisabeth Qvigstad; Sylvain Sebert; Kari Stefansson; Valgerdur Steinthorsdottir; Tiinamaija Tuomi; Marie-France Hivert; Paul W Franks; Mark I McCarthy; Cecilia M Lindgren; Rachel M Freathy; Deborah A Lawlor; Andrew P Morris; Reedik Mägi Journal: Hum Mol Genet Date: 2022-09-29 Impact factor: 5.121
Authors: Peter W G Tennant; Eleanor J Murray; Kellyn F Arnold; Laurie Berrie; Matthew P Fox; Sarah C Gadd; Wendy J Harrison; Claire Keeble; Lynsie R Ranker; Johannes Textor; Georgia D Tomova; Mark S Gilthorpe; George T H Ellison Journal: Int J Epidemiol Date: 2021-05-17 Impact factor: 7.196
Authors: Jessica M Page; Amanda A Allshouse; Irina Cassimatis; Marcela C Smid; Erol Arslan; Vanessa Thorsten; Corette Parker; Michael W Varner; Donald J Dudley; George R Saade; Robert L Goldenberg; Barbara J Stoll; Carol J Hogue; Radek Bukowski; Deborah Conway; Halit Pinar; Uma M Reddy; Robert M Silver Journal: Obstet Gynecol Date: 2020-12 Impact factor: 7.623
Authors: C L Meek; R S Lindsay; E M Scott; C E Aiken; J Myers; R M Reynolds; D Simmons; J M Yamamoto; D R McCance; H R Murphy Journal: Diabet Med Date: 2020-09-21 Impact factor: 4.359